Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib - Concepedia

Concepedia

Publication | Closed Access

Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

81

Citations

29

References

2013

Year

Takahide Nakazawa, Hisashi Hidaka, Juichi Takada, Yusuke Okuwaki, Yoshiaki Tanaka, Masaaki Watanabe, Akitaka Shibuya, Tsutomu Minamino, Shigehiro Kokubu, Wasaburo Koizumi

European Journal of Gastroenterology & Hepatology

Abstract

Early increase in AFP predicted PD and poorer survival and may thus be a useful biomarker in patients with advanced HCC who receive sorafenib.

References

	Year	Citations

Page 1